Proficient Market Insights Final Logo-01-01.png
Nicotinamide Mononucleotide (NMN) Market Size ($ 296.05 Billion by 2031 at CAGR of 7.49% CAGR) - which is Booming Strong Growth in the Globe till 2031
20 sept. 2023 05h04 HE | Proficient Market Insights
PUNE, Sept. 20, 2023 (GLOBE NEWSWIRE) -- “Nicotinamide Mononucleotide (NMN) Market” with analysis of such parameters i.e. industry growth drivers, supply and demand, risks, market attractiveness,...
SRW - NMN - Social - Post - 1080 x 1080px - 2
Popular anti-aging ingredient used by Harvard Professor has landed in New Zealand
25 sept. 2022 23h40 HE | SRW Laboratories
AUCKLAND, New Zealand, Sept. 25, 2022 (GLOBE NEWSWIRE) -- New Zealand health company ‘SRW Laboratories’ have introduced a stabilised form of high purity NMN (Nicotinamide Mononucleotide) to their...
Proficient Market Insights Final Logo-01-01.png
Nicotinamide Mononucleotide (NMN) Market will Turn over USD 251.2 to Revenue to Cross USD 953 million in 2022 to 2028 Research by Business Opportunities, Top Companies, opportunities planning, Market-specific challenges
19 août 2022 07h03 HE | Proficient Market Insights
PUNE, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Global "Nicotinamide Mononucleotide (NMN) Market" research report focus on overall information that can help to take decisions on current market situation....
Blue California Commercializes Nicotinamide Mononucleotide (NMN) for Supporting an Increased Healthspan
20 juil. 2021 07h33 HE | Blue California Ingredients
Rancho Santa Margarita, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Blue California joins with the innovative Massachusetts-based biotech company Conagen to announce the commercialization of...
Effepharm Announced Acquisitions and New R&D Center Establishment
12 déc. 2019 10h00 HE | EffePharm (Shanghai) Co., Ltd
SHANGHAI, China, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Effepharm announce that they acquired two bio-pharmaceutical companies recently, named Dendrimer Co. and Folvo Co., the acquisition has enhanced...